Brainsway Profit Margin

The latest profit margin for BRSYF is 15.58% as of June 2026. That compares with 11.6% in the prior-year period — up 34.4% year over year. That is above the Healthcare sector average of 13.45%. Investors often review this figure alongside Brainsway's historical trend and sector peers before judging valuation or financial health.

Over the past year, BRSYF's profit margin moved from 11.6% to 15.58% — a 34.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Brainsway's valuation or profitability profile.

Against Healthcare companies, BRSYF currently prints 15.58% for profit margin, while the sector average sits near 13.45%. That is roughly 15.9% above the sector mean. Large gaps often invite a closer look at Brainsway's growth, margins, and balance sheet.

Profit Margin shows how effectively Brainsway converts resources into returns. At 15.58%, BRSYF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 11.6% in the prior-year period — up 34.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BRSYF's profit margin (15.58%), review year-over-year change from 11.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.